Published in Postgrad Med J on October 01, 1972
GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice. Psychopharmacology (Berl) (2004) 1.78
Haemodialysis clearance of baclofen. Eur J Clin Pharmacol (2007) 1.18
Complications of baclofen overdosage. Postgrad Med J (1980) 1.12
Status epilepticus after baclofen withdrawal. J Natl Med Assoc (1984) 0.96
Atropine treatment for baclofen overdose. Postgrad Med J (1981) 0.90
Differential effects of sodium oxybate and baclofen on EEG, sleep, neurobehavioral performance, and memory. Sleep (2012) 0.89
Baclofen intoxication: a "fun drug" causing deep coma and nonconvulsive status epilepticus--a case report and review of the literature. Eur J Pediatr (2012) 0.85
Iatrogenic Baclofen Neurotoxicity in ESRD: Recognition and Management. Semin Dial (2015) 0.81
Progressive impairment of cerebellar mGluR signalling and its therapeutic potential for cerebellar ataxia in spinocerebellar ataxia type 1 model mice. J Physiol (2016) 0.81
GABA(B) receptor agonists reverse akinesia following intranigral or intracerebroventricular injection in the reserpine-treated rat. Br J Pharmacol (2003) 0.80
Baclofen overdose treated with continuous venovenous hemofiltration. Eur J Clin Pharmacol (2015) 0.78
Metabolic and Pharmacokinetic Differentiation of STX209 and Racemic Baclofen in Humans. Metabolites (2012) 0.78
Successful treatment of severe baclofen toxicosis initially refractory to conventional treatment. Clin Case Rep (2016) 0.75
Application of high-resolution mass spectrometry to determination of baclofen in a case of fatal intoxication. Forensic Toxicol (2016) 0.75
Pharmacokinetic alteration of baclofen by multiple oral administration of herbal medicines in rats. Evid Based Complement Alternat Med (2014) 0.75
Biotransformation and pharmacokinetics of acenocoumarol (Sintrom) in man. Eur J Clin Pharmacol (1977) 1.22
Thalidomide in rabbit semen. Nature (1967) 1.13
Pharmacokinetics and metabolism of the anti-inflammatory agent Voltaren. Scand J Rheumatol Suppl (1978) 1.12
The metabolism of desferrioxamine B and ferrioxamine B. Biochem Pharmacol (1967) 1.05
Pharmacokinetic and metabolic studies with labeled rifamycin antibiotics. Antimicrob Agents Chemother (Bethesda) (1966) 1.04
Metabolism of niridazole in various species, including man. Ann N Y Acad Sci (1969) 0.99
The metabolism of 14C-oxcarbazepine in man. Xenobiotica (1986) 0.99
Biotransformation and pharmacokinetics of sulfinpyrazone (Anturan) in man. Eur J Clin Pharmacol (1975) 0.96
Distribution and renal excretion of desferrioxamine and ferrioxamine in the dog and in the rat. Biochem Pharmacol (1966) 0.96
Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites. Xenobiotica (1979) 0.91
Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotica (1979) 0.91
Metabolic studies on oxprenolol in animals and man by means of radio-tracer techniques and GLC-analysis. Postgrad Med J (1970) 0.90
Studies of the distribution and excretion of clioquinol in the animal. Arzneimittelforschung (1973) 0.87
Selective uptake of an antibilharzial nitrothiazole compound by Schistosoma mansoni. Nature (1966) 0.83
[Pathologic lens changes in experimental animals following continuous administration of high doses of Desferal]. Helv Physiol Pharmacol Acta (1967) 0.82
C-glucuronides, a novel type of drug metabolites. Helv Chim Acta (1975) 0.79
New metabolites of sulfinpyrazone in man. Arzneimittelforschung (1980) 0.79
The disposition of [14C]-labelled benazepril HCl in normal adult volunteers after single and repeated oral dose. Xenobiotica (1991) 0.79
Pharmacokinetics and metabolism of formestane in breast cancer patients. J Steroid Biochem Mol Biol (2001) 0.79
The biotransformation of phenylbutazone (Butazolidin). J Int Med Res (1977) 0.79
Clioquinol: absence of neurotoxicity in laboratory animals. Lancet (1972) 0.78
Characterization of a novel diclofenac metabolite in human urine by capillary gas chromatography-negative chemical ionization mass spectrometry. J Chromatogr B Biomed Appl (1996) 0.78
Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine. Ther Drug Monit (1988) 0.78
Disposition and pharmacokinetics of cadralazine and individual metabolites in man. Eur J Drug Metab Pharmacokinet (1985) 0.78
Metabolism of hydralazine in man. Arzneimittelforschung (1977) 0.78
Blood levels of a schistosomicide in relation to liver function and side effects. Acta Pharmacol Toxicol (Copenh) (1971) 0.76
[On the penetration of foreign body materials into the young vertebrate embryo]. Bull Schweiz Akad Med Wiss (1966) 0.76
The disposition and metabolism of 14C-oxprenolol.HCl in man. Xenobiotica (1986) 0.75
Haemodialysis in imipramine poisoning? An experimental study. Klin Wochenschr (1976) 0.75
Metabolism of phenylbutazone in man. Arzneimittelforschung (1976) 0.75
Biliary excretion of ferrioxamines of varying liposolubility in perfused rat liver. Am J Physiol (1968) 0.75
[On the metabolism of sulfaphenazol (Orisul)]. Klin Wochenschr (1965) 0.75
[Pharmacokinetic studies with maprotiline (Ludiomil)]. Boll Chim Farm (1973) 0.75
The passage of drugs across the rat intestine in vitro. J Pharm Pharmacol (1966) 0.75
The metabolism of niridazole (AMBILHARR) in man. I. Investigations on patients suffering from clinically mild forms of Schistosoma haematobium and Schistosoma mansoni infection. Ann Trop Med Parasitol (1970) 0.75
Multiple inverse isotope dilution assay for cadralazine and four metabolites in biological fluids. J Chromatogr (1983) 0.75
Physico-chemical factors of drugs affecting absorption, distribution, and excretion. Acta Pharmacol Toxicol (Copenh) (1971) 0.75
The metabolic fate of 14C-oxaprotiline X HCl in man. III. Stereospecific disposition. Biopharm Drug Dispos (1985) 0.75
Pharmacokinetics of diclofenac sodium (Voltaren) and metabolites in patients with impaired renal function. Scand J Rheumatol Suppl (1978) 0.75
Species differences in the disposition and metabolism of sulfinpyrazone. Xenobiotica (1981) 0.75
The metabolic fate of Ciba 32644-Ba. Acta Trop Suppl (1966) 0.75
Biotransformation of oxaprotiline: isolation and identification of metabolites in urine of rat and dog. Xenobiotica (1986) 0.75
Multiple inverse isotope dilution assay for the stereospecific quantitative determination of R(-) and S(+)-oxaprotiline in biological fluids. J Chromatogr (1982) 0.75
Isolation and stereospecific determination of the enantiomers of oxindazac by direct liquid chromatographic resolution on triacetylcellulose. J Chromatogr (1985) 0.75
[The isolated perfused rat liver as a model for the investigation of biliary transport of foreign body materials]. Helv Physiol Pharmacol Acta (1966) 0.75
Indoxyl derivatives of drug metabolites. Experientia (1985) 0.75
Multiple inverse isotope dilution assay for the stereospecific determination of R(+)- and S(-)-oxprenolol in biological fluids. J Chromatogr (1983) 0.75
[Distribution and binding of divalent Fe in dogs]. Helv Physiol Pharmacol Acta (1968) 0.75
The metabolic fate of [14C]oxaprotiline.HCl in man. I. Disposition and preliminary pharmacokinetics. Xenobiotica (1984) 0.75
On the percutaneous absorption of tribenoside applied topically to the mouse ear. Experientia (1969) 0.75
Multiple inverse isotope dilution assay for oxprenolol and nine metabolites in biological fluids. J Chromatogr (1983) 0.75
The metabolism of niridazole (AMBILHARR) in man. II. Investigations on patients suffering from clinically advanced forms of Schistosoma mansoni infection. Ann Trop Med Parasitol (1970) 0.75
Letter: Reserpine and chemical carcinogenesis. Lancet (1975) 0.75
The metabolic fate of [14C]oxaprotiline.HCl in man. II. Isolation and identification of metabolites. Xenobiotica (1984) 0.75
Tricyclic drugs: potent mutagenicity of traces of a nitroarene formed in the reaction of opipramol with nitrite. Mutat Res (1987) 0.75